The strong affinity between thyroxine and the specific thyroxine-binding protein (TBP) of human serum (1) is apparent from, a) the inability to remove more than small amounts of thyroxine from the serum by prolonged dialysis (2), and b) the effectiveness with which TBP competes with albumin for available thyroxine in serum, despite its much smaller concentration. Thyroxine bound to TBP is, nevertheless, free to exchange with thyroxine added to serum in vitro (3). Thus, when endogenous serum thyroxine has been labeled with I131, the addition of excess quantities of unlabeled thyroxine to such serum will cause a displacement of thyroxine-Il31 from TBP. It may be expected that the addition to such serum of any substance capable of competing with thyroxine for its binding sites on the specific protein, would cause a similar displacement of thyroxine-Il3s.
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Earlier reports (4) (5) (6) have revealed that triiodothyronine has the ability to displace thyroxine from TBP. The present study represents an attempt to quantitate this effect, and to compare, in this way, the affinity of a series of thyroxine analogues for TBP.
MATERIALS AND METHODS
Sera from three healthy young adults (one female, two males) were obtained after overnight fasts, and were stored in the frozen state until used. The 14 analogues of thyroxine which were studied are listed in Table I Appropriate quantities of the L-thyroxine-Il31 solution and each of the thyroxine analogue solutions were combined so as to produce fixed concentrations of thyroxine in the presence of varying concentrations of analogue. These mixtures were evaporated to dryness in vacuo without heating. Serum was then added, allowed to stand for 15 to 20 hours at 4°C., and then stored in the frozen state until used.
The concentration of thyroxine in the serum mixtures was determined by iodine analysis as previously described (3) . Similar analysis was made for those analogues which contained iodine. In the case of the remaining analogues, the measured concentration (weight plus dilution factors) was used. Recovery of thyroxine-I1l31 after drying was assessed by radioactivity measurements as previously described (3) , and it was assumed that identical recoveries pertained to the thyroxine analogues in each instance. These recoveries ranged from 68 to 115 per cent, but were usually between 85 and 100 per cent (mean =93 per cent). The concentrations of thyroxine and analogues employed are indicated in Table I .
Each serum mixture was subjected to zone electrophoresis in filter paper at pH 8.6 (barbital buffer, ionic strength 0.1), and the distribution of radioiodine among the various serum protein components were determined. The techniques employed have been described elsewhere (3). 
RESULTS
Electrophoretic distribution of radioiodine in serum containing a constant, small amount of Lthyroxine-Il31 and increasing concentrations of Ltriiodothyronine is illustrated in Figure 1 . At high triiodothyronine concentrations, thyroxineIl31 is displaced from the alpha globulin area, and becomes associated with the other serum protein components, particularly with albumin. These results are analogous to those obtained when excess quantities of L-thyroxine are added to serum (3), but the molar concentration of L-triiodothyronine required to produce a given displacement is greater than in the case of thyroxine. The other analogues tested either resulted in similar displacement patterns, or were without effect on the thyroxine-Il31 distribution. The molar concentrations required to produce a given displacement of thyroxine, however, were variable.
Data obtained in the earlier study with thyroxine alone (3) were used as a basis for comparison of the various analogues tested. An illustration of the manner in which these comparisons were made is provided in Figure 2 . The fraction of the total thyroxine-Il3' in the alpha globulin area is plotted against the molar concentration of serum thyroxine (endogenous plus exogenous), plus the molar concentration of thyroxine analogue, on logarithmic coordinates. The solid line is equivalent to the statistically derived curve fitting the thyroxine data (at high concentrations) in the earlier study (3) . It here takes the form log Y/X = A + (B -1) log X (where Y = thyroxine concentration in alpha globulin, X = total serum thyroxine concentration). The points in Figure 2 represent the data obtained with three thyroxine analogues. It is apparent that L-triiodothyronine is less effective than L-thyroxine itself in producing displacement of thyroxine-I'l" from alpha globulin, while Ldiiodothyronine is without effect at the concentrations employed. The 3',5'-dimethyl analogue of DL-thyroxine exhibits an intermediate effect.
The dotted line in Figure 2 cated by the fact that the relative binding intensity for individual measurements with L-thyroxine itself ranged from approximately 50 to 150. (The scatter of the individual points around the straight line is shown in the previous study [3] .) Second, the apparent affinity of a compound for TBP may be affected by any difference between it and L-thyroxine with regard to binding by other serum proteins. For example, a compound which is bound only by TBP would be likely to have a higher concentration of unbound compound than would thyroxine at comparable serum levels. Since binding to protein is proportional to the concentration of the unbound compound rather than to the total concentration, the value for "relative binding intensity" would be falsely high. Information bearing on this question is available only for triiodothyronine (4, 7) , and it appears that triiodothyronine may be bound less strongly to albumin than is thyroxine. Thus, the values recorded in the table must be considered as approximations.
Nevertheless, the data permit certain tentative conclusions. The affinity of D-thyroxine (Table  I, No. 2) for TBP does not appear to differ significantly from that of L-thyroxine ( (4) . One of these in vivo differences is the much faster disappearance of intravenously administered triiodothyronine from the circulation (8) (9) (10) . Similarly, it might be considered that the great rapidity with which injected diiodotyrosine disappears from the blood (11, 12) is due to its low or absent affinity for TBP. D-thyroxine, however, disappears with equally great rapidity from the blood (8) , despite an affinity for TBP comparable to that of L-thyroxine. Consideration of D-thyroxine, which binds strongly to TBP but has little or no L-thyroxine-like metabolic effects (13) and L-triiodothyronine, which binds relatively weakly but has potent L-thyroxine-like effects, suggests that the molecular features responsible for binding to the serum protein are different from those concerned with metabolic activity.7 SUMMARY A series of 14 analogues of L-thyroxine have been studied with regard to their ability to displace L-thyroxine-Il31 from its specific binding protein in human serum (TBP). The technique of electrophoresis in filter paper (barbital buffer, pH 8.6) was employed. Earlier studies with Lthyroxine alone have been used as a basis for comparison, and the "relative binding intensities" of the analogues for the thyroxine-binding sites on TBP have been calculated.
Of the compounds tested, only D-thyroxine has a binding intensity as great as L-thyroxine. 7 The D-thyroxine used in this study is from the same lot that had been tested earlier for turnover in the blood (8) . It had also been checked for L-thyroxine-like effect by the goiter prevention assay, and had approximately 10 per cent of the activity of an equimolar dose of L-thyroxine (14) .
Lesser degrees of binding are exhibited by analogues with changes in the 3',5' positions, such as L-triiodothyronine and the dinitro and dimethyl analogues of thyroxine. Binding is also retained by certain thyroxine analogues with changes in the phenolic hydroxyl, amino, and carboxyl groups. A number of analogues, including Ldiiodothyronine and L-diiodotyrosine, fail to displace L-thyroxine from TBP in the concentrations employed.
The results obtained with certain of the compounds suggest that the molecular features of thyroxine responsible for binding to TBP are different from those concerned with metabolic activity.
